Precipio to report $4.5m q3-2023 revenues, double from q3-2022

New haven, conn., oct. 18, 2023 (globe newswire) -- specialty cancer diagnostics company precipio, inc. (nasdaq: prpo) , announces that q3-2023 (unaudited) revenues have increased 28% to $4.5m from $3.5m in q2-2023, and have more than doubled from $2.2m from q3-2022.

PRPO Ratings Summary

PRPO Quant Ranking